In a post by Jonathan Schatz on Twitter, it says, “55% complete response rate by 4th gen CART19 -huIL18 in CAR-19 relapsed lymphomas. Intriguing early data International Conference on Malignant Lymphoma.”
Source: Jonathan Schatz/Twitter
In a post by Jonathan Schatz on Twitter, it says, “55% complete response rate by 4th gen CART19 -huIL18 in CAR-19 relapsed lymphomas. Intriguing early data International Conference on Malignant Lymphoma.”
Source: Jonathan Schatz/Twitter